Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-23-004322
Filing Date
2023-05-10
Accepted
2023-05-10 16:00:27
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 3395736
2 GRAPHIC g394147g00d03.jpg GRAPHIC 31021
3 GRAPHIC g394147g01a47.jpg GRAPHIC 67179
4 GRAPHIC g394147g01b47.jpg GRAPHIC 72120
5 GRAPHIC g394147g01c47.jpg GRAPHIC 99162
6 GRAPHIC g394147g01d46.jpg GRAPHIC 89910
7 GRAPHIC g394147g01g32.jpg GRAPHIC 92528
8 GRAPHIC g394147g01k38.jpg GRAPHIC 67436
9 GRAPHIC g394147g01m40.jpg GRAPHIC 48325
10 GRAPHIC g394147g01m52.jpg GRAPHIC 123234
11 GRAPHIC g394147g01n52.jpg GRAPHIC 120383
12 GRAPHIC g394147g01s40.jpg GRAPHIC 47396
13 GRAPHIC g394147g01w40.jpg GRAPHIC 77555
14 GRAPHIC g394147g01x40.jpg GRAPHIC 75014
15 GRAPHIC g394147g01z54.jpg GRAPHIC 139521
  Complete submission text file 0000950123-23-004322.txt   4931694
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06708 | Film No.: 23906178
SIC: 2834 Pharmaceutical Preparations